Safety of a non-viral plasmid-encoding dual isoforms of hepatocyte growth factor in critical limb ischemia patients: a phase I study. (Q45868651)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21430785%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

title

Safety of a non-viral plasmid-encoding dual isoforms of hepatocyte growth factor in critical limb ischemia patients: a phase I study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21430785%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

1 reference

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21430785%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

author name string

T D Henry

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21430785%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

A T Hirsch

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21430785%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

J Goldman

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21430785%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Y L Wang

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21430785%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

D L Lips

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21430785%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

W D McMillan

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21430785%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

T A Biggs

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21430785%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

H H Keo

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21430785%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

publication date

24 March 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21430785%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21430785%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21430785%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21430785%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

page(s)

788-794

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21430785%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/gt.2011.21

26 January 2020

exact match

0 references

cites work

Population-based study of event-rate, incidence, case fatality, and mortality for all acute vascular events in all arterial territories (Oxford Vascular Study).

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.21

National trends in lower extremity bypass surgery, endovascular interventions, and major amputations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.21

ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery/Society f

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.21

Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.21

Progenitor cell therapy in patients with critical limb ischemia without surgical options

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.21

Treatment with intramuscular vascular endothelial growth factor gene compared with placebo for patients with diabetes mellitus and critical limb ischemia: a double-blind randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.21

Therapeutic Angiogenesis With Intramuscular NV1FGF Improves Amputation-free Survival in Patients With Critical Limb Ischemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.21

Results of a double-blind, placebo-controlled study to assess the safety of intramuscular injection of hepatocyte growth factor plasmid to improve limb perfusion in patients with critical limb ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.21

Therapeutic angiogenesis using naked DNA expressing two isoforms of the hepatocyte growth factor in a porcine acute myocardial infarction model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.21

Quantitative MR measurements of regional and global left ventricular function and strain after intramyocardial transfer of VM202 into infarcted swine myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.21

MR assessment of myocardial perfusion, viability, and function after intramyocardial transfer of VM202, a new plasmid human hepatocyte growth factor in ischemic swine myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.21

Naked DNA expressing two isoforms of hepatocyte growth factor induces collateral artery augmentation in a rabbit model of limb ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.21

TcPO2 as an accurate predictor of therapy in limb salvage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.21

Therapeutic angiogenesis induced by hepatocyte growth factor: potential gene therapy for ischemic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.21

Hepatocyte growth factor as cardiovascular hormone: role of HGF in the pathogenesis of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.21

Safety evaluation of clinical gene therapy using hepatocyte growth factor to treat peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.21

No influence of tumor growth by intramuscular injection of hepatocyte growth factor plasmid DNA: safety evaluation of therapeutic angiogenesis gene therapy in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.21

Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.21

Nonviral retrograde gene transfer of human hepatocyte growth factor improves neuropathic pain-related phenomena in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.21

Improved expression of vascular endothelial growth factor by naked DNA in mouse skeletal muscles: implication for gene therapy of ischemic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.21

More than one leg to stand on: a step forward in the management of critical limb ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.21

7 January 2021

Transcutaneous oxygen (TcPO2) estimates probability of healing in the ischemic extremity

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.21

7 January 2021

Therapeutic angiogenesis induced by human recombinant hepatocyte growth factor in rabbit hind limb ischemia model as cytokine supplement therapy

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.21

7 January 2021

Potentiated angiogenic effect of scatter factor/hepatocyte growth factor via induction of vascular endothelial growth factor: the case for paracrine amplification of angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.21

7 January 2021

Hepatocyte growth factor is a novel member of the endothelium-specific growth factors: additive stimulatory effect of hepatocyte growth factor with basic fibroblast growth factor but not with vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.21

7 January 2021

Naked plasmid DNA encoding fibroblast growth factor type 1 for the treatment of end-stage unreconstructible lower extremity ischemia: preliminary results of a phase I trial

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.21

7 January 2021

Induction of angiogenesis and inhibition of apoptosis by hepatocyte growth factor effectively treats postischemic heart failure

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.21

7 January 2021

Expression of HGF and cMet in the peripheral nervous system of adult rats following sciatic nerve injury

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.21

7 January 2021